340B provider advocates have criticized findings in the CBO's recent report on the 340B program.

340B Provider Advocates Slam CBO Report on 340B Growth and Budgetary Impact, Drug Industry Touts Findings

340B program advocates recently took aim at a new Republican-requested Congressional Budget Office (CBO) report on the 340B program, arguing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live